| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 6127 | RLEGMLSQSVSSQYNMAGV | S | 7 | 193 |
| 6128 | RLEGMLSQSVSSQYNMAGV | S | 9 | 195 |
| 6129 | RLEGMLSQSVSSQYNMAGV | S | 11 | 197 |
| 6130 | RLEGMLSQSVSSQYNMAGV | S | 12 | 198 |
| 10016832 | LSWLDGSGLGFSLEYPT ISLHALSR | S | 24 | 67 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 6127 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | None | 33330510 | |||
| 6128 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | None | 33330510 | |||
| 6129 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | None | 33330510 | |||
| 6130 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | None | 33330510 | |||
| 10016832 | prediction and site-directed mutagenesis | LTP | unambiguous | human | HEK 293 Phoenix cells | None | 33330510 | The peptide sequence was inferred by using trypsin digestion |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6127 | RLEGMLSQSVSSQYNMAGV | S | 7 | 193 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | 33330510 | |
| 6128 | RLEGMLSQSVSSQYNMAGV | S | 9 | 195 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | 33330510 | |
| 6129 | RLEGMLSQSVSSQYNMAGV | S | 11 | 197 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | 33330510 | |
| 6130 | RLEGMLSQSVSSQYNMAGV | S | 12 | 198 | MS | LTP | ambiguous | human | HEK 293 Phoenix cells | 33330510 | |
| 10016832 | LSWLDGSGLGFSLEYPT ISLHALSR | S | 24 | 67 | prediction and site-directed mutagenesis | LTP | unambiguous | human | HEK 293 Phoenix cells | 33330510 | The peptide sequence was inferred by using trypsin digestion |